Stocks · Health care · Pharmaceutical Preparations

Q32 Bio Inc.

FIXX Clue Score74
United States Fiscal year ends December CIK 0001661998 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Lee Kalowski
6 Oct 2026
CFO and President
Sell
1,301
$8.32
$10.82K
Shelia M. Violette
6 Oct 2026
Chief Scientific Officer
Sell
917
$8.32
$7.63K
Jodie Pope Morrison
6 Oct 2026
CEO
Sell
3,221
$8.32
$26.80K
Shelia M. Violette
25 Aug 2026
Chief Scientific Officer
Sell
2,798
$16.56
$46.33K
Lee Kalowski
25 Aug 2026
CFO and President
Sell
3,972
$16.56
$65.78K
Jodie Pope Morrison
25 Aug 2026
CEO
Sell
9,845
$16.56
$163.03K
Shelia M. Violette
25 Feb 2026
Chief Scientific Officer
Sell
2,815
$4.51
$12.71K
Jodie Pope Morrison
25 Feb 2026
CEO
Sell
9,896
$4.51
$44.67K
Lee Kalowski
25 Feb 2026
CFO and President
Sell
3,995
$4.51
$18.04K
Lee Kalowski
2 Dec 2025
CFO and President
Sell
9,072
$3.46
$31.40K
Jodie Pope Morrison
2 Dec 2025
CEO
Sell
22,506
$3.46
$77.87K

What was left out

Form 4 filings counted 31
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 499,021
History held since 29 Mar 2018